Priorities for the Treatment of Latent Tuberculosis Infection in the United States

New England Journal of Medicine

Volumn 350, Issue 20, 2004, Pages 2060-2067+2115

  Horsburgh Jr , C Robert ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN INDURATION; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; INCIDENCE; INFANT; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; PRESCHOOL CHILD; RISK; VIRUS ACTIVATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; VIRUS ACTIVATION;

EID: 2342568929     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMsa031667     Document Type: Review

References (40)

1. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1989;38:269-72.
2. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Recomm Rep 1999; 48(RK-9):1-13.
3. Geiter L, ed. Ending neglect: the elimination of tuberculosis in the United States. Washington, D.C.: National Academy Press, 2000.
4. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.
5. Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147:1311-20.
6. Poss JE. Factors associated with participation by Mexican migrant farmworkers in a tuberculosis screening program. Nurs Res 2000;49:20-8.
7. Tulsky JP, White MC, Dawson C, Hoynes TM, Goldenson J, Schecter G. Screening for tuberculosis in jail and clinic follow-up after release. Am J Public Health 1998;88:223-6.
8. Bock NN, Metzger BS, Tapia JR, Blumberg HM. A tuberculin screening and isoniazid preventive therapy program in an innercity population. Am J Respir Crit Care Med 1999;159:295-300.
9. Gilroy SA, Rogers MA, Blair DC. Treatment of latent tuberculosis infection in patients aged ≥35 years. Clin Infect Dis 2000; 31:826-9.
10. Nolan CM, Roll L, Goldberg SV, Elarth AM. Directly observed isoniazid preventive therapy for released jail in mates. Am J Respir Crit Care Med 1997;155:583-6.
11. Kohn MR, Arden MR, Vasilakis J, Shenker IR. Directly observed preventive therapy: turning the tide against tuberculosis. Arch Pediatr Adolesc Med 1996;150:727-9.
12. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17: 857-72.
13. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibl Tuberc 1970;26:28-106.
14. Lowell AM. Tuberculosis. Cambridge, Mass.: Harvard University, Press, 1969.
15. Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982;125:8-15.
16. Arias E. United States life tables, 2000. National vital statistics reports. Vol. 51. No. 3. Hyattsville, Md.: National Center for Health Statistics, 2002. (DHHS publication no. (PHS) 2003-1120 02-0644.)
17. Horsburgh CR JR, Moore M, Castro KG. Epidemiology of tuberculosis in the United States. In: Rom WN, Garay SM, eds. Tuberculosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2004:31-45.
18. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1.
19. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-8.
20. Ferebee SH, Mount FW, Murray FJ, Livesay VT. A controlled trial of isoniazid prophylaxis in mental institutions. Am Rev Respir Dis 1963;88:161-75.
21. Ferebee SH, Mount FW. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis 1962;85:490-510.
22. Palmer CE, Jablon S, Edwards PQ. Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build. Am Rev Tuberc 1957;76:517-39.
23. Edwards LB, Livesay VT, Acquaviva FA, Palmer CE. Height, weight, tuberculous infection, and tuberculous disease. Arch Environ Health 1971;22:106-12.
24. Comstock GW, Palmer CE. Long-term results of BCG vaccination in the southern United States. Am Rev Respir Dis 1966;93: 171-83.
25. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
26. Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless: a prospective study. Am J Respir Crit Care Med 2000;162:460-4.
27. Pablos-Mendez A, Blustein J, Knirsch CA. The tole of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997;87:574-9.
28. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
29. Cowie RL. The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med 1994; 150: 1460-2.
30. Corbett EL, Churchyard GJ, Clayton TC, et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS 2000;14:2759-68.
31. Kleinschmidt I, Churchyard G. Variation in incidences of tuberculosis in subgroups of South African gold miners. Occup Environ Med 1997;54:636-41.
32. Thorn PA, Brookes VS, Waterhouse JA. Peptic ulcer, partial gastrectomy, and pulmonary tuberculosis. Br Med J 1956;4967:603-8.
33. Steiger Z, Nickel WO, Shannon GJ, Nedwicki EG, Higgins RF. Pulmonary tuberculosis after gastric resection. Am J Surg 1976; 131:668-71.
34. Rieder HL. Epidemiologic basis of tuberculosis control. Paris: International Union Against Tuberculosis and Lung Disease, 1999.
35. Miller FJW, Seal RME, Taylor MD. Tuberculosis in children: evolution, control, treatment. Boston: Little, Brown, 1963.
36. Comstock GW. Frost revisited: the modern epidemiology of tuberculosis. Am J Epidemiol 1975;101:363-82.
37. Jones JL, Hanson DL, Dworkin MS, DeCock KM. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. Int J Tuberc Lung Dis 2000;4:1026-31.
38. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002;359:2059-64.
39. Ziv E, Daley CL, Blower SM. Early therapy for latent tuberculosis infection. Am J Epidemiol 2001;153:381-5.
40. Gourevitch MN, Alcabes P, Wasserman WC, Arno PS. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis. Int J Tuberc Lung Dis 1998;2:531-40.